Next 2 quarters
It seems Aphria got caught off guard with the Diamond delays. Management had to buy 9 million in product last quarter --- they couldn't produce enough while trying to start Diamond. Next quarter won't be much different regarding the income statement; Double Diamond still won't be reported on earnings, and OCS will start opening stores after the quarter ends. I also think Double Diamond delayed the extracts which will be a slow rollout. However, Q4 will be gangbusters with month over month growth throughout the quarter. Production costs will continue to decrease, but it will be the first quarter of the facility running at 100% and we can get a sense of actual costs. The industry is skeptical Aphria will be able to sell it, but they now have the ability to control the price. I don't foresee any catalysts from now until July or August, but with MnAs, black swans, you never know. If they execute for Q4, and release guidance for FY2020 around 1.2 billion with 150 to 200 million EBITDA the stock could easily 2x to 3x on Q4 earnings. Good luck to the longs, and hope management's payrolls correlates to competence.